Vivani Medical (NASDAQ:VANI – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($0.10) per share for the quarter.
Vivani Medical Trading Down 0.9 %
Shares of VANI opened at $1.09 on Monday. The company has a market cap of $64.57 million, a price-to-earnings ratio of -2.42 and a beta of 3.20. Vivani Medical has a 1-year low of $1.03 and a 1-year high of $2.22. The company’s fifty day simple moving average is $1.14 and its 200 day simple moving average is $1.21.
Analysts Set New Price Targets
Separately, HC Wainwright restated a “buy” rating and set a $4.00 target price on shares of Vivani Medical in a report on Thursday, March 13th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
See Also
- Five stocks we like better than Vivani Medical
- 3 Tickers Leading a Meme Stock Revival
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- What is a buyback in stocks? A comprehensive guide for investors
- 3 ETFs to Ride the VIX Surge During Market Volatility
- What is the Nasdaq? Complete Overview with History
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.